HIV post-exposure prophylaxis after sexual assault: The experience of a sexual assault service in London

International Journal of STD and AIDS

Volumn 13, Issue 9, 2002, Pages 602-605

  Limb, S ^a   Kawsar, M ^b   Forster, G E ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Adverse events; Highly active antiretroviral therapy (HAART); HIV post exposure prophylaxis; Sexual assault

Indexed keywords

CHOLESTEROL; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INDINAVIR; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR;

ARTICLE; BEHCET DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; FEMALE; FEVER; FOLLOW UP; GALACTORRHEA; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SEXUAL CRIME; TREATMENT OUTCOME; UNITED KINGDOM;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH SERVICES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; LONDON; MALE; PATIENT COMPLIANCE; RAPE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036727080     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/09564620260216290     Document Type: Article

References (19)

1. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood
2. Prophylaxis for occupational exposure to HIV
3. A case-control study of HIV seroconversion in healthcare workers after percutaneous exposure
4. Post-exposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault
5. HIV testing, counseling and prophylaxis after sexual assault
6. Sexually transmitted diseases in victims of rape
7. Sexual transmission of HIV
8. Rape and subsequent seroconversion to HIV
9. Rape and HIV
10. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes
11. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
12. Tolerability and side-effects of post-exposure prophylaxis for HIV infection
13. Prophylaxis with a nevirapine containing triple regimen after exposure to HIV-1
14. Post-exposure prophylaxis after sexual exposure to HIV
15. Offering HIV prophylaxis to people who have been sexually assaulted: 16 Months' experience in a sexual assault service
16. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study
17. Galactorrhoea and hyperprolactinaemia associated with protease-inhibitors